Congressional Testimony 2016
This section includes testimony by FDA officials before House and Senate Committees and Subcommittees.
March 2016
- 03/02/2016
Examining the U.S. Public Health Response to the Zika Virus Luciana Borio, M.D., before the House Energy and Commerce Committee, Subcommittee on Oversight and Investigations
February 2016
- 02/04/2016
Biosimilars Implementation Janet Woodcock, M.D., before the House Committee on Energy and Commerce, Subcommittee on Health - 02/04/2016
Implementation of the Generic Drug User Fee Amendments of 2012 (GDUFA)
Janet Woodcock, M.D., before the House Committee on Oversight and Government Reform
January 2016
- 01/28/2016
Implementation of the Generic Drug User Fee Amendments of 2012 (GDUFA) Janet Woodcock, M.D., before the Senate Committee on Health, Education, Labor and Pensions